Accelerator Startups
Accelerator startups represent some of the most progressive leaders driving digital innovation in oncology. Their novel ideas were selected from over 100 applications and they are now working with CancerX Mentors, as well as members across the healthcare ecosystem, to test and validate their solutions. In addition, we are proud of the diverse representation of our cohort: close to 20% of companies are international, 75% of our founders are women or BIPOC, and 12 of 16 are first-time founders!
These startups will graduate from the Accelerator with guidance on how to successfully scale their company, strategic exposure to a range of CancerX champions and members, and meaningful connections into a community that will continue to support their development – all aiming to deliver new solutions that will reduce the burden of cancer for all people.
- Cohort 2024
EnteroTrack
Company Name: EnteroTrack
Location: United States
Profile: EnteroTrack is a clinical-stage, platform technology company that provides simple, scalable, yet comprehensive solutions to monitor and screen for upper GI diseases. Unlike endoscopy or cellular-brushing, our clinically validated method can be used with no discomfort in an office or home setting, is suitable for adults and children, and provides quantitative measures of disease activity, all of which help patients better understand and control chronic upper GI diseases.
Representative: Robin Shandas
Gesund.ai
Company Name: Gesund.ai
Location: United States
Profile: Gesund is the world’s first AI assurance lab on a mission to help bring clinical-grade AI solutions to market. To help comply with regulatory requirements, our platform audits and validates 3rd party medical AI solutions for safety, effectiveness and equity. Backed by marquee investors including Merck, McKesson, Northpond and 500, Gesund orchestrates the entire AI/ML lifecycle for all stakeholders by bringing models, data and experts together in a no-code environment.
Representative: Enes Hosgor
Navya
Company Name: Navya
Location: United States
Profile: Navya cancer data model serves oncologists and patients in three ways: create meaning from complex medical records; generate actionable, billable draft clinical notes with effective treatment planning; and translate medical jargon into patient understandable language. These workflow transformations drive efficiencies, enhance quality of care, and patient satisfaction. Navya is a clinically validated solution used by cancer centers like Memorial Sloan Kettering and Tata Memorial Center.
Representative: Naresh Ramarajan
Oatmeal Health
Company Name: Oatmeal Health
Location: United States
Profile: Oatmeal Health is a technology-driven cancer screening provider designed to identify individuals at high risk, provide extensive care navigation, and conduct radiology risk assessments. Our primary initiative targets community health centers and health plans.
Representative: Jonathan Govette
Realyze Intelligence
Company Name: Realyze Intelligence
Location: United States
Profile: Realyze Intelligence is a software company that accelerates the clinical trial enrollment and collection of Real-World Data for health systems and cancer centers. The solution automates the screening and matching of patients, enabling organizations to increase enrollment, target more diverse populations and expand clinical research capabilities using existing resources. The Realyze platform leverages a combination of clinical expert modeling and AI to analyze EHR data in real time.
Representative: Gilan ElSaadawi